Literature DB >> 333301

[Clinical experiences with a new muscle relaxant (DS 103-282 Sandoz) (author's transl)].

E Ringwald, S J Campean, F Gerstenbrand, A Lorincz, P Lörincz, H P Ludin.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 333301

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  5 in total

Review 1.  Spasticity and drug therapy.

Authors:  E W Wuis
Journal:  Pharm Weekbl Sci       Date:  1987-10-16

2.  Antinociceptive action of tizanidine in mice and rats.

Authors:  T Kameyama; T Nabeshima; A Sugimoto; K Matsuno; S Yamada
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

3.  Action of tizanidine on responses of forearm flexors and extensors to torque disturbances.

Authors:  R Mackel; E E Brink; Y Nakajima
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-10       Impact factor: 10.154

4.  Double-blind comparison of single doses of DS103-282, baclofen and placebo for suppression of spasticity.

Authors:  N Hassan; D L McLellan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-12       Impact factor: 10.154

5.  Tizanidine in the treatment of spasticity.

Authors:  P M Newman; M Nogues; P K Newman; D Weightman; P Hudgson
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.